GNCA

Genocea Biosciences, Inc.
GNCA

Overview Fund Activity
Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

35 hedge funds and large institutions have $31.1M invested in Genocea Biosciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
12
Reduced
9
Closed
3
Calls
$3.35M
Puts
$71K
Net Calls
+$3.28M
Net Calls Change
+$512K

Top Buyers

1
Squarepoint
Squarepoint
New York
$305K
2
Millennium Management
Millennium Management
New York
$187K
3
WS
Wedbush Securities
California
$105K
4
BlackRock
BlackRock
New York
$448K
5
Citadel Advisors
Citadel Advisors
Florida
$92K

Top Sellers

1
SM
Sabby Management
Florida
$288K
2
ECM
Endurant Capital Management
California
$276K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
$328K
4
BI
BVF Inc
California
$4.64M
5
Renaissance Technologies
Renaissance Technologies
New York
$265K
Name Holding Trade Value Shares
Change 		Shares
Change %
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$32K – – –
Wells Fargo
27
Wells Fargo
California
$23K -$16.1K -7,214 -41%
Bank of America
28
Bank of America
North Carolina
$14K +$2.03K +901 +17%
AA
29
AlphaMark Advisors
Kentucky
$13K +$1.36K +600 +12%
Morgan Stanley
30
Morgan Stanley
New York
$10K +$3.81K +1,769 +62%
Citigroup
31
Citigroup
New York
$3K – – –
AWA
32
Artemis Wealth Advisors
New York
$2.62K – – –
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
– -$19K -10,878 Closed
Victory Capital Management
34
Victory Capital Management
Texas
– -$12K -6,512 Closed
1
2